Searched for
BIOLOGICAL E. LIMITED
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Water, waste & will: How India’s MSMEs can lead the sustainability revolutionWater efficiency, if managed wisely, could very well be the next competitive advantage for Indian MSMEs.
- Biological E to manufacture HPV9 vaccine for India, UNICEF and PAHO tender marketsJiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to Biological E. Limit...
- Corbevax vaccine gets WHO Emergency Use Listing authorisationThe company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, ...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- Centre places purchase order for 5 cr doses of Corbevax Covid vaccine each costing Rs 145 sans taxThe government is yet to decide on which segment of beneficiaries this new vaccine would be administered.
- Biological E aims to produce 100 mn doses/month of Corbevax from Feb 2022Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating o...
- BE hopes to roll out COVID-19 vaccine Corbevax by November-endSpeaking to reporters on the sidelines of signing a financing agreement with US International Development Finance Corporation (DFC), she sa...
- Indemnity issues may hold up availability of J&J single dose vaccineWhile the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely ti...
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
- DCGI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18The phase 2 and 3 clinical trials have be conducted as per approved protocol titled 'A Prospective, Randomised, Double-blind, Placebo contr...
- Biological E's Corbevax gets nod for phase 2/3 trials on those aged 5-18India's drug regulator has granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its COVID-19 ...
- J&J applies for EUA of its single-dose COVID vaccine in IndiaThis is an important milestone that paves the way for bringing the company's single-dose COVID-19 vaccine to the people of India, and the r...
Load More
